Ankylosing Spondylitis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Endothelium Function in AS Improved with Methotrexate Alone or Combined with Anti-TNF Agents, Study Finds - Ankylosing Spondylitis News



Endothelium Function in AS Improved with Methotrexate Alone or Combined with Anti-TNF Agents, Study Finds 
Ankylosing Spondylitis News
Sixty-four patients had rheumatoid arthritis, 29 had psoriatic arthritis, and 20 had ankylosing spondylitis. Study participants received either a monotherapy of methotrexate or a combination of methotrexate and anti-TNF. ?We evaluated changes in the ...

 


Opioid Use Associated With Subjective Measures of Disease in Ankylosing Spondylitis - Clinical Pain Advisor



Clinical Pain Advisor
 
Opioid Use Associated With Subjective Measures of Disease in Ankylosing Spondylitis 
Clinical Pain Advisor
According to the results of a study published in the Journal of Rheumatology, opioid use in patients with ankylosing spondylitis may be associated with subjective measures of disease and depression, but not objective measures of inflammation. In a ...

 


A Solid Foundation and Community Will Keep You Standing - Ankylosing Spondylitis News



Ankylosing Spondylitis News
 
A Solid Foundation and Community Will Keep You Standing 
Ankylosing Spondylitis News
Having a great foundation and support system is vital to the success of anything mighty you are trying to achieve. Being diagnosed with ankylosing spondylitis (AS) is no different. In fact, it is probably even more important to have a strong foundation ...

 


Lateral projection BMD increased in ankylosing spondylitis - Healio



Lateral projection BMD increased in ankylosing spondylitis 
Healio
Lateral projection spinal bone mineral density increased over a period of 5 years in multiple locations along the spine, among patients with ankylosing spondylitis, according to findings published in Arthritis Research and Therapy. The researchers ...

 


What Is the Best Site for Assessing Bone Loss in Ankylosing Spondylitis? - Rheumatology Advisor



Rheumatology Advisor
 
What Is the Best Site for Assessing Bone Loss in Ankylosing Spondylitis? 
Rheumatology Advisor
According to the results of a 5-year study published in Arthritis Research & Therapy, the best site at which to assess bone loss in patients with ankylosing spondylitis (AS) is the femoral neck. Results also indicate that medication use, including ...

 


UCB: Bimekizumab efficacious as ankylosing spondylitis treatment - Healio



UCB: Bimekizumab efficacious as ankylosing spondylitis treatment 
Healio
Multinational biopharmaceutical company UCB has announced that its phase 2b BE AGILE study has established a dose response, as well as statistically significant efficacy, for bimekizumab as a treatment for adults with ankylosing spondylitis, according ...

 


Opioid use for ankylosing spondylitis more likely linked to subjective disease measures - Healio



Opioid use for ankylosing spondylitis more likely linked to subjective disease measures 
Healio
The use of opioids among patients with ankylosing spondylitis is more likely to be associated with subjective measures, such as depression, than objective measures like C-reactive protein levels and erythrocyte sedimentation rate, according to findings ...

 


EU Approves Cimzia for Pregnant and Breastfeeding Women with a Rheumatic Disease - Ankylosing Spondylitis News



EU Approves Cimzia for Pregnant and Breastfeeding Women with a Rheumatic Disease 
Ankylosing Spondylitis News
The approval follows positive results from UCB's completed CRIB (NCT02019602) and CRADLE (NCT02154425) Phase 1 clinical trials. The studies' design represented a major improvement over historical anti-TNF data, which had been based on case reports ...

 


The New Year and the Journey Ahead - Ankylosing Spondylitis News



Ankylosing Spondylitis News
 
The New Year and the Journey Ahead 
Ankylosing Spondylitis News
I think it's safe to say, heading into the New Year, that we all have goals we plan to accomplish. I recommend letting the old things pass away and starting anew. Sure, we still will deal with doctor's appointments and we still have ankylosing ...

 


Novartis Initiates Phase 3 Trial in AS Comparing Cosentyx to Adalimumab Biosimilar - Ankylosing Spondylitis News



Ankylosing Spondylitis News
 
Novartis Initiates Phase 3 Trial in AS Comparing Cosentyx to Adalimumab Biosimilar 
Ankylosing Spondylitis News
Novartis recently initiated a Phase 3 clinical trial comparing its FDA-approved therapy Cosentyx (secukinumab) with GP2017 ? an adalimumab biosimilar ? in ankylosing spondylitis (AS) patients. The trial, called SURPASS (NCT03259074), is a head-to ...
Novartis Advances Head-to-head Superiority Trials of Cosentyx Versus Humira Drug Discovery & Development

all 3 news articles »